Launches at Risk There was a thread going a few days ago about launches which occurred at risk before the court resolution of the patent issues. I think Lotrel fits in that group. TEVA has been extremely aggressive with this strategy. I'd love to see them on the receiving end. FL http://www.drugs.com/newdrugs/teva-provides-update-lotrel-489.html